A novel treatment for glioblastoma, consisting of a combination of an oncolytic virus, engineered to selectively infect and kill cancer cells, and type of a targeted immunotherapy called immune checkpoint inhibition, is showing promise, prolonging patient survival. Read the article from the University of Toronto here.
research
More Funding
The Mayo Clinic Comprehensive Cancer Center and Columbia University have been awarded a five-year, $10.6 million grant from the National Cancer Institute (NCI) to advance glioblastoma research. For details, read this article.
Researchers Develop New Therapy Using a Vaccine
Researchers at UCLA are developing a breakthrough treatment using a vaccine to help attack GBM cells. Read the full article here: UCLA researchers develop new combination therapy to activate immune response against glioblastoma
Duke’s Glioblastoma Treatment Given Breakthrough Status
Research at Duke University using the polio virus to kill brain cancer has been granted breakthrough status by the FDA. Results in the earliest stage of testing have been so remarkable, the FDA wants to fast track the treatment to speed it to market. Watch the video and read the full article.
New Study
Check out the newly published study by the American Society of Clinical Oncology on the Maximum Safe Resection of Glioblastoma Multiforme.